Dr. Wael Noor El-Nachef, MD

Dr. El-Nachef practices at Huntington Ambulatory Surgery Center - HOPD in Pasadena, California.

Dr. El-Nachef's NPI, 1285951905, was assigned on April 21, 2010. Dr. El-Nachef graduated from Feinberg School of Medicine in 2010. Dr. El-Nachef's California license number on file is A119400.

Dr. El-Nachef's primary practice is Huntington Ambulatory Surgery Center - HOPD, at 625 S Fair Oaks Ave, Pasadena, CA 91105.

Dr. El-Nachef's primary practice is Huntington Ambulatory Surgery Center - HOPD in Pasadena, California. Dr. El-Nachef is also affiliated with Huntington Hospital. The medical group on file is Southern California Neurology Consultants. Dmand AI also links Dr. El-Nachef to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. El-Nachef practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. El-Nachef's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. El-Nachef is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. El-Nachef's licenses on file in 2 states: California and Montana.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic anemia, chronic diabetes, chronic hypertension, chronic inflammatory bowel disease (IBD), gastrointestinal bleeding and hemorrhoids among the conditions Dr. El-Nachef treats.

CMS data shows 293 Medicare services from Dr. El-Nachef across 8 procedure codes in 2024, for 136 Medicare patients. Medicare paid $31,394 for them.

CMS counts 136 Medicare patients who saw Dr. El-Nachef in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 56% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. El-Nachef's median patient age at 63, with 53% women.

In 2024, Dr. El-Nachef wrote 134 Medicare Part D claims for 61 patients. 72% of them were for generic drugs. CMS names the drug for 81 of them, across 3 drugs with 11 or more claims each, at $18,685 in total drug cost. In 2023, CMS named 70 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. El-Nachef for performance year 2024, reported as part of a group. Dr. El-Nachef accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. El-Nachef as offering telehealth. CMS counts 78 procedures of colonoscopy by Dr. El-Nachef, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. El-Nachef, published from 2009 to 2021. 2014 was the busiest year, with 2. The most frequent topics are Enteric Nervous System, Cell Differentiation and Cell Culture Techniques. Dr. El-Nachef has published most often in Tissue Eng Part A. Dr. El-Nachef's most frequent co-authors are Ryan Gregory Spurrier, MD, Minna Minsing Chen Wieck, MD and Zhi Cheng, MD.

CMS Open Payments shows 7 general payments to Dr. El-Nachef from 6 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Madrigal Pharmaceuticals paid the most, $127.

Dr. El-Nachef graduated from Feinberg School of Medicine in 2010.

Dr. El-Nachef is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and LA Care. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.